Recent news

July 17, 2023

Fempharma has been successfully audited for ISO 13485:2016 Manufacturing and Trade of Medical Devices by Tequa-Zert, a TÜV Hessen partner.

June 25th, 2023

We have presented our latest study “A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence.” at the International Urogynecological Association’s (IUGA) 48th Annual Meeting on June 24, 2023 in The Hague, The Netherlands.

You can find our abstract at URO TODAY Magazine.

June 22, 2023

Our latest study about the efficacy of INCOXIL has been published at the BMC Women’s Health titled “A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence”. It is open access by clicking here.

May 21st, 2023

We have presented our latest study “A randomized controlled trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence” at the American College of Obstetricians and Gynecologists (ACOG) 2023 Annual Clinical & Scientific Meeting in Baltimore, MD.

You can find our abstract at Obstetrics & Gynecology (the Green Journal)

May 19th, 2023

New clinical trial for Juvia has started. Vaginitis is one of the most common gynecological problems in women. Candida albicans is responsible for more than 85% of vaginal fungal infections and reinfection after standard treatment is quite common. The aim of this study is to compare the effects of Juvia vaginal gel and oral fluconazole on the treatment and recurrence of vulvovaginal candidiasis (VVC). Our hypothesis is that Juvia vaginal gel may decrease the rate of reinfection after standard treatment with oral 150 mg fluconazole.

May 4th, 2023

Fempharma’s proprietary vaginal moisturizer gel JUVIA has gotten into the shelves at Rossmann Hungary.

April 19th, 2023

Fempharma has been successfully audited for ISO 22000:2018 research and development, contract manufacturing of dietary supplements.